everolimus

常見(jiàn)例句

• In the treatment group, everolimus was introduced five weeks posttransplantation.
  移植后實(shí)驗(yàn)組大鼠給予依維莫司5周。
• Everolimus leads to a prolongation of allograft survival, reduced cell infiltrate in the graft, and prevents tubular atrophy and interstitial fibrosis.
  依維莫司能夠延長(zhǎng)移植物的存活，減少移植物細(xì)胞浸潤(rùn)，防止小管萎縮及間質(zhì)纖維化。
• In the everolimus group, five of six animals survived for 20 weeks with stable serum creatinine and displayed neither acute cellular rejection nor CAN.
  而在依維莫司組，六分之五的大鼠存活超過(guò)20周，血肌酐水平平穩(wěn)，且既沒(méi)有表現(xiàn)出急性細(xì)胞性排斥也沒(méi)有CAN表現(xiàn)。
• The aim of this study is to evaluate the therapeutic effect of everolimus on cellular and humoral mechanisms of chronic allograft damage in a rat model with sensitized recipients.
  該研究的目的在于評(píng)估依維莫司對(duì)于細(xì)胞免疫和體液免疫導(dǎo)致的致敏大鼠腎移植模型慢性移植物腎病的作用。
• CONCLUSION: The used rat model offers the opportunity to study the influence of everolimus on the interaction of humoral and cellular mechanisms involved in chronic renal damage.
  結(jié)論：該大鼠模型研究慢性腎臟破壞體液和細(xì)胞機(jī)制，并研究依維莫司與其的交互作用。
• These data suggest that although cellular rejection is clearly suppressed, humoral mechanisms of CAN cannot be completely controlled by everolimus treatment in the sensitized rat model.
  這些數(shù)據(jù)提示雖然細(xì)胞性排斥已經(jīng)明顯被抑制，但是致敏大數(shù)模型采用依維莫司依然無(wú)法完全控制CAN的體液機(jī)制。
返回 everolimus